Hemodynamic Monitoring, Positive Inotropic and Vasoactive Drugs During Cardiac Surgery (EMOA Study)
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 3,099
- 试验地点
- 1
- 主要终点
- Proportion of patients undergoing cardiac surgery and receiving a cardiac output monitoring.
研究概览
简要总结
Describe the proportion of patients who underwent cardiac surgery in France and benefiting from a monitoring cardiac output, describe the use of positive inotropic and vasoactive agents for cardiac surgery patients operated (type of catecholamines, their duration), describe the fluid replacement and transfusions of first 24 hours, describe the incidence of postoperative complications in patients undergoing cardiac surgery.
详细描述
The perioperative management in cardiac surgery patients has changed dramatically in the last fifteen years with the development of new cardiac output monitoring devices, the availability of new inotropic molecules, and a modern treatment for cardio-circulatory failure.
However, few studies report the possible changes in practice. The last French national survey was conducted in 2001. Since then, the literature is poor on the subject, and the impact of new approaches has been only marginally addressed. Recently, a German postal survey was conducted among cardiac surgery anesthesiologists, but on purely declarative elements and without patient data.
The investigators offer a type of national prospective observational study to evaluate professional practices, morbidity and mortality in cardiac surgical patients. This study must include all patients undergoing cardiac surgery at the participating centers during 7 weeks.
The main objective of this work is to assess the proportion of patients undergoing cardiac surgery receiving a cardiac output monitoring.
Secondary objectives are to describe the relationship between the use of cardiac output monitoring and the use of positive inotropic agents and vasoactive (type molecules, duration), volume expansion and transfusions the first 24 hours, and the incidence postoperative complications for patients undergoing cardiac surgery.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients over 18 years old undergoing cardiac surgery during the study period
- •Non-inclusion Criteria:
- •age under 18 years old
- •Extracorporeal life support and others cardiac assistance
- •congenital cardiac surgery
- •TAVI procedures
- •Pericardium surgical drainages
- •Sternal sepsis surgery
排除标准
- 未提供
结局指标
主要结局
Proportion of patients undergoing cardiac surgery and receiving a cardiac output monitoring.
时间窗: Up to 28 days after surgery (length of intensive care unit stay)
次要结局
- Correlation between use of cardiac output monitoring and the incidence of norepinephrine use(Up to 28 days after surgery (length of intensive care unit stay))
- Correlation between use of cardiac output monitoring and the incidence of epinephrine use(Up to 28 days after surgery (length of intensive care unit stay))
- Correlation between use of cardiac output monitoring and the incidence of dobutamine use(Up to 28 days after surgery (length of intensive care unit stay))
- Correlation between use of of cardiac output monitoring and the incidence of postoperative complications(Up to 28 days after surgery (length of intensive care unit stay))
- Correlation between use of cardiac output monitoring and the length of dobutamine infusion(Up to 28 days after surgery (length of intensive care unit stay))
- Correlation between use of of cardiac output monitoring and the incidence of red blood cell transfusion(Up to 28 days after surgery (length of intensive care unit stay))
- Correlation between use of cardiac output monitoring and the length of norepinephrine infusion(Up to 28 days after surgery (length of intensive care unit stay))
- Correlation between use of cardiac output monitoring and the length of epinephrine infusion(Up to 28 days after surgery (length of intensive care unit stay))
- Correlation between use of of cardiac output monitoring and the volume of fluid expansion during first day following cardiac surgery(Up to 28 days after surgery (length of intensive care unit stay))